New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:38 EDTSUPNSupernus to receive $30M in non-dilutive royalty deal
Supernus Pharmaceuticals announced the execution of a royalty acquisition agreement with HealthCare Royalty Partners. Per the Agreement, HC Royalty will make a $30M cash payment to Supernus in consideration for acquiring from Supernus certain royalty and milestone rights related to the commercialization of Orenitram Extended-Release Tablets by Supernus' partner United Therapeutics Corporation. Supernus will retain full ownership of the Royalty Rights after a certain threshold has been reached per the terms of the Agreement.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SUPN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use